BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22791819)

  • 41. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
    Li F; Dai L; Niu J
    J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.
    Chang ZG; Wei JM; Qin CF; Hao K; Tian XD; Xie K; Xie XH; Yang YM
    Dig Dis Sci; 2012 May; 57(5):1181-9. PubMed ID: 22271412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion.
    Liu A; Shao C; Jin G; Liu R; Hao J; Song B; Ouyang L; Hu X
    Cell Biochem Biophys; 2014 Jun; 69(2):341-6. PubMed ID: 24604208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [MUC4 Silencing Inhibits TGF-β1-induced Epithelial-mesenchymal Transition VIA the ERK1/2 Pathway in Human Airway Epithelial NCI-H292 Cells].
    Kim YD; Choi YS; Na HG; Song SY; Bae CH
    Mol Biol (Mosk); 2021; 55(4):617-625. PubMed ID: 34432779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.
    Joshi S; Cruz E; Rachagani S; Guha S; Brand RE; Ponnusamy MP; Kumar S; Batra SK
    Mol Oncol; 2016 Aug; 10(7):1063-77. PubMed ID: 27185392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.
    Zuo J; Ishikawa T; Boutros S; Xiao Z; Humtsoe JO; Kramer RH
    Mol Cancer Res; 2010 Feb; 8(2):170-82. PubMed ID: 20145039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.
    Kunigal S; Ponnusamy MP; Momi N; Batra SK; Chellappan SP
    Mol Cancer; 2012 Apr; 11():24. PubMed ID: 22537161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling.
    Zhu Y; Zhang JJ; Xie KL; Tang J; Liang WB; Zhu R; Zhu Y; Wang B; Tao JQ; Zhi XF; Li Z; Gao WT; Jiang KR; Miao Y; Xu ZK
    J Transl Med; 2014 Nov; 12():309. PubMed ID: 25367394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
    Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
    J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.
    Kaur S; Sharma N; Krishn SR; Lakshmanan I; Rachagani S; Baine MJ; Smith LM; Lele SM; Sasson AR; Guha S; Mallya K; Anderson JM; Hollingsworth MA; Batra SK
    Clin Cancer Res; 2014 Feb; 20(3):688-700. PubMed ID: 24240113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
    Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
    Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
    Wan X; Guo D; Zhu Q; Qu R
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.
    Singh AP; Chauhan SC; Andrianifahanana M; Moniaux N; Meza JL; Copin MC; van Seuningen I; Hollingsworth MA; Aubert JP; Batra SK
    Oncogene; 2007 Jan; 26(1):30-41. PubMed ID: 16799633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
    Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
    Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.